(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester) | 20838 | TABLET;ORAL | 32MG

(+/-)1-HYDROXYETHYL 2-ETHOXY-1-(P-(O-1H-TETRAZOL-5-YLPHENYL)BENZYL)-7-BENZIMIDAZOLECARBOXYLATE, CYCLOHEXYL CARBONATE (ESTER)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 22 USDMF, 23 CEP/COS, 15 JDMF, 15 EU WC, 18 KDMF, 6 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

22 API Suppliers

22 API Suppliers

FINISHED DOSAGE FORMULATIONS

804 FDF Dossiers, 51 FDA Orange Book, 602 Europe, 83 Canada, 22 South Africa, 46 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 16MG, TABLET;ORAL - 32MG, TABLET;ORAL - 4MG, TABLET;ORAL - 8MG, TABLET;ORAL - 16MG;12.5MG, TABLET;ORAL - 32MG;12.5MG, TABLET;ORAL - 32MG;25MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 7 DKSH, 8 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 Beijing Mesochem Technology, 2 DFE Pharma, 1 Finar, 4 Gangwal Chemicals, 1 Hayashibara, 3 Ingredion Pharma Solutions, 22 Kerry, 9 Microlex e.U, 2 Nomisma Healthcare, 5 Pluviaendo, 2 Prachin Chemical, 8 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 24 Direct Compression, 15 Co-Processed Excipients, 13 Chewable & Orodispersible Aids, 12 Taste Masking, 10 Parenteral, 10 Granulation, 9 Topical, 9 Disintegrants & Superdisintegrants, 8 Controlled & Modified Release, 8 Lubricants & Glidants, 8 Thickeners and Stabilizers, 6 Solubilizers, 6 Coating Systems & Additives, 4 Film Formers & Plasticizers, 1 API Stability Enhancers, 1 Emulsifying Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 520 Finished Drug Prices

MARKET PLACE

10 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 6 USP, 7 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20838 / DOSAGE - TABLET;ORAL - 32MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CANDESARTAN CILEXETIL(UNII: R85M2X0D68) (CANDESARTAN - UNII:S8Q36MD2XX)	CANDESARTAN CILEXETIL	16mg

Inactive Ingredients

Ingredient Name	American Health Packaging	Apotex Corp.	AstraZeneca Pharmaceuticals LP	Avera McKennan Hospital	Bryant Ranch Prepack	Cardinal Health	Par Pharmaceutical Inc.	Sandoz Inc
CARBOXYMETHYLCELLULOSE CALCIUM(UTY7PDF93L)
FERRIC OXIDE RED(1K09F3G675)
GLYCERYL MONOSTEARATE(230OU9XXE4)
HYDROXYPROPYL CELLULOSE (1200000 MW)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
HYDROXYPROPYL CELLULOSE(RFW2ET671P)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
MAGNESIUM STEARATE(70097M6I30)
POLYETHYLENE GLYCOL 8000(Q662QK8M3B)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYETHYLENE GLYCOLS(3WJQ0SDW1A)
STARCH, CORN(O8232NY3SJ)
TRIACETIN(XHX3C3X673)

Drug Product Composition: (+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)